HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu Zhu Selected Research

Lentivirus Infections

11/2011Proteinase-activated receptor-1 mediates dorsal root ganglion neuronal degeneration in HIV/AIDS.
9/2009CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapy.
7/2005Lentivirus infection causes neuroinflammation and neuronal injury in dorsal root ganglia: pathogenic effects of STAT-1 and inducible nitric oxide synthase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu Zhu Research Topics

Disease

177Neoplasms (Cancer)
09/2022 - 01/2005
30Neoplasm Metastasis (Metastasis)
12/2021 - 06/2010
27Hemorrhagic Shock
01/2022 - 04/2010
24Renal Cell Carcinoma (Grawitz Tumor)
01/2020 - 01/2013
22Inflammation (Inflammations)
10/2022 - 07/2005
22Urinary Bladder Neoplasms (Bladder Cancer)
09/2022 - 07/2015
22Hypoxia (Hypoxemia)
01/2022 - 08/2010
18Infections
05/2022 - 04/2005
18Hepatocellular Carcinoma (Hepatoma)
04/2021 - 11/2010
18Glioma (Gliomas)
01/2021 - 01/2013
17Wounds and Injuries (Trauma)
01/2022 - 05/2013
16Stomach Neoplasms (Stomach Cancer)
02/2021 - 07/2010
15Shock
01/2022 - 08/2010
14Hemorrhage
05/2022 - 02/2005
14Sepsis (Septicemia)
01/2022 - 12/2015
12Prostatic Neoplasms (Prostate Cancer)
08/2022 - 03/2006
12Pheochromocytoma
10/2020 - 06/2006
11Carcinogenesis
08/2022 - 06/2010
11BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2021 - 11/2008
11Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2021 - 01/2013
10Carcinoma (Carcinomatosis)
01/2022 - 06/2007
10Lung Neoplasms (Lung Cancer)
01/2021 - 06/2008
9Septic Shock (Toxic Shock Syndrome)
01/2021 - 07/2011
8Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
08/2022 - 01/2018
8Necrosis
11/2020 - 07/2008
8Leukemia
10/2018 - 06/2010
8Hypertension (High Blood Pressure)
11/2017 - 05/2011
7Liver Neoplasms (Liver Cancer)
02/2022 - 12/2014
7Adrenocortical Carcinoma
01/2022 - 12/2011
7Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 06/2007
7Nausea
01/2019 - 11/2013
6Pain (Aches)
05/2022 - 12/2007
6Breast Neoplasms (Breast Cancer)
01/2022 - 06/2012
6Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 08/2015
6Body Weight (Weight, Body)
12/2021 - 10/2005
6Adenoma (Adenomas)
07/2021 - 03/2010
6Ischemia
01/2021 - 05/2009
6Osteoporosis
11/2020 - 01/2018
6Pancreatic Neoplasms (Pancreatic Cancer)
01/2016 - 10/2005
5Bradycardia
11/2022 - 03/2011
5Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2017
5Neuroinflammatory Diseases
01/2022 - 07/2005
5Reperfusion Injury
01/2021 - 01/2013

Drug/Important Bio-Agent (IBA)

46Proteins (Proteins, Gene)FDA Link
08/2022 - 10/2005
34Pharmaceutical PreparationsIBA
12/2021 - 04/2006
27Biomarkers (Surrogate Marker)IBA
09/2022 - 08/2013
20CytokinesIBA
06/2022 - 03/2002
18MicroRNAs (MicroRNA)IBA
02/2022 - 04/2013
17Messenger RNA (mRNA)IBA
01/2020 - 07/2005
14Glucose (Dextrose)FDA LinkGeneric
06/2022 - 07/2011
13Biological ProductsIBA
10/2022 - 01/2015
13LipidsIBA
01/2022 - 06/2012
13Oxygen (Dioxygen)IBA
01/2022 - 08/2013
11Long Noncoding RNAIBA
01/2022 - 03/2016
11Therapeutic UsesIBA
09/2021 - 04/2009
11LipopolysaccharidesIBA
01/2021 - 05/2015
10rho-Associated KinasesIBA
11/2016 - 08/2010
9Insulin (Novolin)FDA Link
01/2022 - 01/2013
9alkylglycerone-phosphate synthaseIBA
01/2021 - 07/2014
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 04/2005
8Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 02/2012
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2020 - 05/2011
8DecitabineFDA Link
01/2020 - 01/2013
8Norepinephrine (Noradrenaline)FDA LinkGeneric
02/2016 - 03/2002
7EnzymesIBA
06/2022 - 01/2013
7Blood Glucose (Blood Sugar)IBA
05/2022 - 04/2015
7Peptides (Polypeptides)IBA
02/2022 - 03/2002
7Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2014
7Tyrosine Kinase InhibitorsIBA
12/2021 - 08/2013
7Phosphotransferases (Kinase)IBA
01/2021 - 01/2013
7Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2020 - 08/2014
7DNA (Deoxyribonucleic Acid)IBA
01/2020 - 06/2006
7Arginine Vasopressin (Argipressin)IBA
12/2019 - 07/2011
6ConnexinsIBA
11/2022 - 01/2013
6RNA (Ribonucleic Acid)IBA
08/2022 - 04/2006
6CalciumIBA
06/2022 - 11/2011
6Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 05/2013
6BilirubinIBA
01/2022 - 05/2015
6CateninsIBA
11/2021 - 12/2014
6LigandsIBA
01/2021 - 05/2014
6Hemoglobins (Hemoglobin)IBA
01/2021 - 08/2013
6Imatinib Mesylate (Gleevec)FDA Link
04/2018 - 06/2013
6benzyl isothiocyanateIBA
05/2015 - 12/2011
5DexmedetomidineFDA Link
11/2022 - 12/2016
5SurvivinIBA
03/2021 - 11/2012
5Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2021 - 12/2008

Therapy/Procedure

73Therapeutics
10/2022 - 09/2004
27Drug Therapy (Chemotherapy)
01/2022 - 11/2007
18Resuscitation
01/2022 - 01/2011
16Ligation
01/2021 - 11/2003
13Punctures
02/2021 - 05/2015
12Length of Stay
11/2021 - 12/2007
9Adjuvant Chemotherapy
09/2022 - 01/2018
9Radiotherapy
04/2022 - 10/2014
9Immunotherapy
01/2022 - 09/2014
9Nephrectomy
09/2017 - 08/2010
7Gastrectomy
02/2021 - 05/2018
7Adrenalectomy
10/2020 - 12/2007
5Electrodes (Electrode)
01/2022 - 02/2014
5Aftercare (After-Treatment)
01/2021 - 04/2015